Regional signal / United Kingdom
tirzepatide.
A closer look at a conversation gaining momentum in United Kingdom, enriched with recent reporting from across the web.
ESTIMATED INTEREST1000+approximate searches
FIRST OBSERVED10/2/2026in public trend data
MOST RECENT10/2/2026last seen in United Kingdom
Follow the story
Latest reporting.
Perspectives from publishers covering this topic.
REPORT / 01Recent coverage
WSJ
Lilly’s Next-Gen Obesity Drug Helps People Lose Even More Weight in Study
Open the original report for full details.
Read original reportREPORT / 02Recent coverage
CNBC
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes.
Read original reportREPORT / 03Recent coverage
Scientific American
Blockbuster retatrutide trial signals a ‘new high-water mark’ for weight-loss drugs
Open the original report for full details.
Read original reportSearch activity is aggregated by region and does not represent any individual person's private searches.